Recurrence and prognostic factors in borderline ovarian tumors

Mucinous borderline ovarian tumors: Analysis of 75 patients from a single center

“…Like our study, in a French retrospective multicenter study, Fauvet et al (12) evaluated 360 women treated for BOT and pointed out that the most common symptom at diagnosis was pelvic pain (27%). Ayhan et al (9) reported that the most common complaints at admission were abdominal mass (37%) and abdominal pain (29%). In the study by Messalli et al (8), 49% of patients with BOT were asymptomatic and in premenopausal patients the most common symptom was menstrual disorders (44%).…”

Laparoscopic restaging of borderline ovarian tumors

“…The number of women with micropapillary features and intraepithelial carcinoma in our series was too small to analyze the risk of upstaging in these settings. Ayhan et al [33], after comprehensive staging of women with borderline ovarian tumors, found that the overall tumor-free survival rate was significantly lower for younger patients (age, <30 years) after fertility-sparing surgery, and when a micropapillary architecture or peritoneal implants were present. Moreover, Longacre et al [34] found that recurrent disease and/or progression to lowgrade serous carcinoma was related to the FIGO stage, invasive implants, microinvasion in the primary tumor, and a micropapillary architecture.…”

Tumor Borderline Mucinoso Ovárico Gigante Con Microinvasión

“…Respecto de los factores pronósticos, solo los implantes peritoneales y probablemente la arquitectura micropapilar, representan un pronóstico adverso, en términos de recurrencia y sobrevida (1). El compromiso ganglionar linfático pélvico y lumboaórtico, presente en el 7 a 18% de los casos, no cambia el pronóstico (1,28).…”

“…El compromiso ganglionar linfático pélvico y lumboaórtico, presente en el 7 a 18% de los casos, no cambia el pronóstico (1,28).…”